Genomma Opts for FRN

Jul 2, 2013

Given strong demand for floating-rate bonds as yields rise, Genomma Lab has opted for a floating-rate tranche over a 10-year fixed portion in its MXP2bn ($154m) domestic...

To continue reading please take a free trial, subscribe or login below.

Already have an account?


Subscribe now for unlimited access to all current and archive news, data and market analysis. 


Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

Upcoming Events


Where will capital markets be busiest in 2017?